All News #Library
Biotech
Hibercell To Show HC-7366 Synergy With VEGFR-TKIs In Carcinoma
14 Apr 2026 //
GLOBENEWSWIRE
HiberCell Receives FDA Fast Track for HC-7366 in AML Treatment
23 Oct 2024 //
GLOBENEWSWIRE
HiberCell: First Patient Dosed In AML Combination Trial Of HC-7366
28 May 2024 //
GLOBENEWSWIRE
HiberCell Announces Publication & Presentations for its GCN2 Activator, HC-7366
05 Apr 2024 //
GLOBENEWSWIRE
HiberCell Announces Presentation at ASH, Highlighting Data for HC-7366
15 Dec 2023 //
GLOBENEWSWIRE
HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366
05 Dec 2023 //
GLOBENEWSWIRE
HiberCell Maps Forward Path for Novel GCN2 Activator, HC-7366 in AML
22 Feb 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support